stella
beta
Antiviral Strategies in the Prevention of Long-term Cardiovascular Outcomes Following COVID-19: The paxloviD/Remdesivir Effectiveness For the prEvention of loNg coviD Clinical Trial — Stella
Recruiting
Back to SARS CoV-2 Post-Acute Sequelae trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(4 sites)
Canada
Kingston Health Sciences Centre, Kingston, Ontario
Niagara Health System, St. Catharines, Ontario
Mount Sinai Hospital, Sinai Health System, Toronto, Ontario
St. Joseph's Health Centre, Unity Health Toronto, Toronto, Ontario
View full record on ClinicalTrials.gov